Thermo Fisher Scientific Inc. TMO, the world leader in serving science, today reported its financial results for the first quarter ended April 2, 2011.
Adjusted earnings per share (EPS) grew 12% to a record $0.92.
Revenues grew 4% to a record $2.72 billion.
Adjusted operating margin increased 30 basis points to 17.6%.
Launched new innovative software and instrumentation at Pittcon to broaden life sciences, environmental and safety applications.
Accelerated investment in emerging markets with plans to build new manufacturing facility in China to serve local life sciences customers.
Spent $538 million to buy back 9.6 million shares. Authorized additional $750 million share repurchase program, with $700 million remaining at quarter end.
Sold two laboratory-testing services businesses – Athena Diagnostics and Lancaster Laboratories – just after quarter end, resulting in total proceeds of $940 million.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in